Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells

• Published in: PLoS neglected tropical diseases Vol. 9; no. 9; p. e0003958
• Main Authors: Hunsawong, Taweewun, Sunintaboon, Panya, Warit, Saradee, Thaisomboonsuk, Butsaya, Jarman, Richard G, Yoon, In-Kyu, Ubol, Sukathida, Fernandez, Stefan
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.09.2015; Public Library of Science (PLoS)
• Subjects: Adjuvants, Immunologic - metabolism; Antigens; Antigens, Bacterial - metabolism; B7-1 Antigen - analysis; B7-2 Antigen - analysis; BCG; BCG vaccines; Cell Differentiation - drug effects; Chemokines; Chitin; Chitosan - metabolism; Cytokines; Cytokines - metabolism; Dendritic cells; Dendritic Cells - immunology; Dengue; Dengue fever; Dengue Vaccines - immunology; Dengue Vaccines - metabolism; Dengue Virus - immunology; Drug delivery systems; Drugs; Emulsion polymerization; Endocytosis; HLA-DR Antigens - analysis; Humans; Immunophenotyping; Infections; Innovations; Laboratories; Microscopy, Electron, Scanning; Monocytes - metabolism; Mycobacterium bovis - chemistry; Nanoparticles - metabolism; Nanoparticles - ultrastructure; Prevention; Public health; Tuberculosis; Vaccines; Vaccines, Inactivated - immunology; Vaccines, Inactivated - metabolism; Vehicles; Viral vaccines; Viruses
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0003958

Dengue viruses (DENVs) are among the most rapidly and efficiently spreading arboviruses. WHO recently estimated that about half of the world's population is now at risk for DENV infection. There is no specific treatment or vaccine available to treat or prevent DENV infections. Here, we report the development of a novel dengue nanovaccine (DNV) composed of UV-inactivated DENV-2 (UVI-DENV) and Mycobacterium bovis Bacillus Calmette-Guerin cell wall components (BCG-CWCs) loaded into chitosan nanoparticles (CS-NPs). CS-NPs were prepared by an emulsion polymerization method prior to loading of the BCG-CWCs and UVI-DENV components. Using a scanning electron microscope and a zetasizer, DNV was determined to be of spherical shape with a diameter of 372.0 ± 11.2 nm in average and cationic surface properties. The loading efficacies of BCG-CWCs and UVI-DENV into the CS-NPs and BCG-CS-NPs were up to 97.2 and 98.4%, respectively. THP-1 cellular uptake of UVI-DENV present in the DNV was higher than soluble UVI-DENV alone. DNV stimulation of immature dendritic cells (iDCs) resulted in a significantly higher expression of DCs maturation markers (CD80, CD86 and HLA-DR) and induction of various cytokine and chemokine productions than in UVI-DENV-treated iDCs, suggesting a potential use of BCG- CS-NPs as adjuvant and delivery system for dengue vaccines.